A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Doctaxel-Based Chemotherapy.

Project: Research

Status	Finished
Effective start/end date	09/17/08 → 05/21/11

Project Details